ABBVIE
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2013-01-01
- Employees
- -
- Market Cap
- $346B
- Website
- http://www.abbvie.com
A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )
- Conditions
- Ankylosing SpondylitisRheumatoid ArthritisPsoriatic Arthritis
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 5940
- Registration Number
- NCT01078558
Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2010-03-02
- Last Posted Date
- 2014-05-08
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 5745
- Registration Number
- NCT01078090
- Locations
- 🇩🇪
Site Reference ID/Investigator# 33356, Bad Abbach, Germany
🇩🇪Site Reference ID/Investigator# 33440, Bayreuth, Germany
🇩🇪Site Reference ID/Investigator# 33685, Berlin, Germany
Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical Practice
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2010-03-01
- Last Posted Date
- 2014-04-25
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 4208
- Registration Number
- NCT01077258
- Locations
- 🇩🇪
Site Reference ID/Investigator# 35578, Bad Neuenahr, Germany
🇩🇪Site Reference ID/Investigator# 102216, Bad Nauheim, Germany
🇩🇪Site Reference ID/Investigator# 33404, Bad Rappenau, Germany
Documentation of Humira in Psoriasis Patients in Routine Clinical Practice
- Conditions
- Moderate to Severe Plaque Psoriasis
- First Posted Date
- 2010-03-01
- Last Posted Date
- 2020-06-12
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 5442
- Registration Number
- NCT01077232
- Locations
- 🇩🇪
Praxis Dr. Schuessler /ID# 149404, Alsfeld, Germany
🇩🇪Oster-Schmidt, Altenkirchen, D /ID# 126022, Altenkirchen, Germany
🇩🇪Gewiss, Ahrensburg, DE /ID# 33431, Ahrensburg, Germany
Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia
- Conditions
- Cognitive Deficits in Schizophrenia
- Interventions
- First Posted Date
- 2010-03-01
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 214
- Registration Number
- NCT01077700
- Locations
- 🇺🇸
Site Reference ID/Investigator# 21584, Pico Rivera, California, United States
🇺🇸Site Reference ID/Investigator# 21681, Chicago, Illinois, United States
🇺🇸Site Reference ID/Investigator# 45310, Norwalk, California, United States
Greek Study of the Quality of Life in Patients With Psoriasis Treated With Adalimumab
- Conditions
- Psoriasis
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2014-02-21
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 500
- Registration Number
- NCT01077128
- Locations
- 🇬🇷
Site Reference ID/Investigator# 29826, Athens, Greece
🇬🇷Site Reference ID/Investigator# 30197, Amaliada, Greece
🇬🇷Site Reference ID/Investigator# 29966, Athens, Greece
Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)
- Conditions
- Moderate-to-severe Chronic Plaque Psoriasis
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2016-01-06
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 547
- Registration Number
- NCT01076192
Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2019-02-07
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 7229
- Registration Number
- NCT01076205
Kaletra in Combination With Antiretroviral Agents
- Conditions
- Human Immunodeficiency Virus
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2017-05-19
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 502
- Registration Number
- NCT01076179
Kaletra: Therapy With Double Protease Inhibitors
- Conditions
- Human Immunodeficiency Virus
- First Posted Date
- 2010-02-25
- Last Posted Date
- 2013-01-18
- Lead Sponsor
- AbbVie (prior sponsor, Abbott)
- Target Recruit Count
- 65
- Registration Number
- NCT01075191
- Locations
- 🇩🇪
Site Reference ID/Investigator# 28115, Dortmund, Germany
🇩🇪Site Reference ID/Investigator# 48283, Berlin, Germany
🇩🇪Site Reference ID/Investigator# 28131, Berlin, Germany